Holen Sie sich die Stockscreener-App
52.76
2.35%
1.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$51.52
Offen:
$52.03
24-Stunden-Volumen:
433.24K
Relative Volume:
0.20
Marktkapitalisierung:
$8.21B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
56.13
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-0.90%
1M Leistung:
-1.05%
6M Leistung:
-16.08%
1J Leistung:
-31.08%
1-Tages-Spanne:
$51.80
$53.23
1-Wochen-Bereich:
$50.76
$53.75
52-Wochen-Spanne:
$46.01
$80.95
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
(612) 379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
52.78 | 8.01B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.29 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.88 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.25 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
726.58 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
339.38 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-07-09 | Eingeleitet | TD Cowen | Buy |
| 2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-08-28 | Eingeleitet | William Blair | Outperform |
| 2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-25 | Bestätigt | The Benchmark Company | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
| 2020-01-08 | Fortgesetzt | Stephens | Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-02 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-17 | Eingeleitet | Goldman | Neutral |
| 2018-06-15 | Eingeleitet | Argus | Buy |
| 2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
| 2017-02-09 | Eingeleitet | Citigroup | Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Gains Recap: How does Bio Techne Corporation perform in inflationary periods2025 Pullback Review & Weekly Setup with High ROI Potential - خودرو بانک
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne - Benzinga
Here’s Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne’s (TECH) Long-Term Growth Profile - ca.finance.yahoo.com
Bio-Techne Faces Potential Pressure with Proposed Sales Notice - timothysykes.com
Royal Bank of Canada Cuts Stock Position in Bio-Techne Corp $TECH - MarketBeat
Plato Investment Management Ltd Invests $281,000 in Bio-Techne Corp $TECH - MarketBeat
6,799 Shares in Bio-Techne Corp $TECH Acquired by Petrus Trust Company LTA - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Fred Alger Management LLC - MarketBeat
Bio-Techne Corp Faces Uncertain Market with Planned Sale of Securities - StocksToTrade
The three-year earnings decline is not helping Bio-Techne's (NASDAQ:TECH share price, as stock falls another 5.8% in past week - Yahoo Finance
MBB Public Markets I LLC Purchases New Stake in Bio-Techne Corp $TECH - MarketBeat
Select Equity Group L.P. Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Amundi Lowers Position in Bio-Techne Corp $TECH - MarketBeat
Polar Asset Management Partners Inc. Decreases Position in Bio-Techne Corp $TECH - MarketBeat
NFJ Investment Group LLC Acquires New Position in Bio-Techne Corp $TECH - MarketBeat
Sandler Capital Management Takes $1.58 Million Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Curi RMB Capital LLC - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
Bio-Techne Corp. Stock Slides 6.0%, Underperforms Peers - 富途牛牛
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Bio-Techne (TECH) Stock Is Down Today - Yahoo Finance
Bio-Techne at Morgan Stanley Conference: Strategic Insights on Growth and Challenges - Investing.com
CONMED appoints Bio-Techne CEO Kim Kelderman to board of directors - Investing.com
Bio-Techne CEO and Former Thermo Fisher Executive Kim Kelderman Joins CONMED's Board of Directors - Stock Titan
Bio-Techne at Baird Global Healthcare: Strategic Growth Amid Challenges - Investing.com
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - Ariva
Trexquant Investment LP Makes New $3.75 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
Applying big data sentiment scoring on Bio Techne CorporationWeekly Trade Analysis & Safe Swing Trade Setups - Newser
Baird Financial Group Inc. Sells 91,254 Shares of Bio-Techne Corp $TECH - MarketBeat
Maverick Capital Ltd. Takes $30.66 Million Position in Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation a play on infrastructure spending2025 Key Lessons & Smart Money Movement Alerts - خودرو بانک
Can Bio Techne Corporation outperform in the next rallyWeekly Risk Summary & Real-Time Stock Price Movement Reports - خودرو بانک
Bio-Techne upgraded to Outperform at RBC on strong growth potential - MSN
Market reaction to Bio Techne Corporation’s recent newsJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns By Investing.com - Investing.com Australia
Is it time to cut losses on Bio Techne CorporationJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Pattern recognition hints at Bio Techne Corporation upside2025 Growth vs Value & High Accuracy Buy Signal Tips - Newser
Understanding Bio Techne Corporation’s price movement2025 Investor Takeaways & Consistent Growth Stock Picks - Newser
Can Bio Techne Corporation benefit from deglobalizationWeekly Profit Summary & Stock Portfolio Risk Control - خودرو بانک
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns - Investing.com India
Iron Triangle Partners LP Acquires Shares of 250,000 Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Benzinga
Quantitative breakdown of Bio Techne Corporation recent move2025 Earnings Surprises & Safe Swing Trade Setup Alerts - Newser
Candlestick signals on Bio Techne Corporation stock todayMarket Performance Recap & Capital Efficiency Focused Ideas - Newser
Using portfolio simulators with Bio Techne Corporation includedWeekly Risk Report & Capital Efficiency Focused Strategies - Newser
Is Bio Techne Corporation a candidate for recovery playInsider Selling & Precise Buy Zone Tips - Newser
Is Bio Techne Corporation still worth holding after the dip2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Is Bio Techne Corporation stock a good dividend stock2025 Winners & Losers & Daily Stock Trend Watchlist - خودرو بانک
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bio Techne Corp-Aktie (TECH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
0.29%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):